These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4256875)

  • 1. A new method for antiplasmin activity determination.
    Wolosowicz N; Prokopowicz J
    Haematologia (Budap); 1971; 5(3):293-9. PubMed ID: 4256875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the process of fibrinogen breakdown by plasmin. II. Relationship between serial thrombin time and plasma antithrombin or antiplasmin].
    Shinada S
    Nihon Naika Gakkai Zasshi; 1970 Sep; 59(9):959-66. PubMed ID: 4248531
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of fibrinogen degradation products on plasmin activity.
    Myśliwiec M; Arnesen H; Godal HC
    Thromb Diath Haemorrh; 1973 Jun; 29(3):592-7. PubMed ID: 4271546
    [No Abstract]   [Full Text] [Related]  

  • 4. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"].
    Daver J; Albugues MJ; du Pasquier JP; Ricoeur M
    Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466
    [No Abstract]   [Full Text] [Related]  

  • 6. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravascular coagulation-fibrinolysis (ICF) syndrome.
    Owen CA; Bowie EJ
    Ann Clin Lab Sci (1971); 1972; 2(1):26-30. PubMed ID: 4263611
    [No Abstract]   [Full Text] [Related]  

  • 8. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

  • 9. Exercise, physical conditioning, blood coagulation and fibrinolysis.
    Ferguson EW; Guest MM
    Thromb Diath Haemorrh; 1974 Mar; 31(1):63-71. PubMed ID: 4275851
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential specificities of the thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors.
    Weinstein MJ; Doolittle RF
    Biochim Biophys Acta; 1972 Feb; 258(2):577-90. PubMed ID: 4258697
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of blood serum antiplasmin and euglobulins on fibrinolysis and fibrinogenolysis in vitro].
    Bratus' GM; Gorodetskiĭ AL; Byshevskiĭ ASh
    Vopr Med Khim; 1971; 17(5):547-9. PubMed ID: 4256467
    [No Abstract]   [Full Text] [Related]  

  • 12. A rapid method for the semiquantitative determination of fibrinogen and fibrinogen degradation products (FDP) in defibrination syndrome.
    Sas G; Jákó J; Domán J; László C; Pádár J
    Thromb Diath Haemorrh; 1971 Jun; 25(3):555-65. PubMed ID: 4254505
    [No Abstract]   [Full Text] [Related]  

  • 13. A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".
    Yasukouchi T; Watanabe T
    Thromb Diath Haemorrh; 1972 Dec; 28(3):329-41. PubMed ID: 4265315
    [No Abstract]   [Full Text] [Related]  

  • 14. A hematological approach to germfree rats: concentration of fibrinogen and antiplasmin.
    Okamoto U; Yamamoto J; Nagamatsu Y
    Kobe J Med Sci; 1973 Sep; 19(3):145-50. PubMed ID: 4276351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of fibrinolytic and antiplasmin activity of blood and tissues].
    Levin GIa
    Lab Delo; 1973; 9():517-9. PubMed ID: 4128694
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effects of lipids on fibrinolysis.
    Chopin SF; Beard EL
    Thromb Diath Haemorrh; 1973 May; 29(2):286-92. PubMed ID: 4357632
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolysis, determination and interpretation].
    Maki M
    Rinsho Byori; 1970 Aug; 18(8):563-8. PubMed ID: 5466550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.